Akums Drugs and Pharmaceuticals Limited
NSE: AKUMS
Employs 7,337 permanent employees and workers, −2.6% on the year before, as filed for the year to 31 Mar 2026 on a group basis. Revenue in the quarter to 31 Dec 2024 was ₹337 cr.
Headcount
Annual, from the BRSR filed with NSE (as of 31 March each year)
| As of | Scope | Permanent | Change (%) | Contract / other | Change (%) |
|---|---|---|---|---|---|
| 31 Mar 2025 | Group | 7,536 | — | 10,328 | — |
| 31 Mar 2026 | Group | 7,337 | −199(2.6%) | 10,673 | 345(3.3%) |
Permanent = permanent employees + permanent workers, as defined in SEBI's BRSR. "Standalone" figures cover the listed company alone and exclude its subsidiaries.
Financials (₹ cr)
| Period | Revenue (₹ cr) | Change (%) | Employee cost (₹ cr) | Change (%) | Net profit (₹ cr) | Change (%) | Flags |
|---|---|---|---|---|---|---|---|
| Quarter ended 31 Dec 2024 | 337 | 9(2.8%) | 50 | −0(0.2%) | 41 | −9(18.3%) | |
| Quarter ended 30 Sept 2024 | 328 | 11(3.5%) | 50 | 3(6.8%) | 50 | 9(20.3%) | |
| Quarter ended 30 Jun 2024 | 317 | — | 47 | — | 42 | — |